Metaplastic Clinical Trials

ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical trials and studies of human participants conducted around the world. Below is a link for you to search and educate yourself to any possible treatment options for metaplastic breast cancer for you to address with your oncologist. https://clinicaltrials.gov/

Clinical Trials for Metaplastic Breast Cancer

Approval DatesLocationTypePhaseCriteria/Contacts
Approval Dates:
1/1/2023 to 12/2028
Location:
Houston Methodist Neal Cancer Center
Type:
Type: Alpelisib With iNOS Inhibitor and Nab-paclitaxel in Patients With HER2 Negative Metastatic or Locally Advanced Metaplastic Breast Cancer
Phase:
Phase 2
Criteria/Contacts:
Link
Approval Dates:
11/2019 to 10/2027
Location:
LOCATIONS
Type:
DART: DUAL ANTI-CLA-4 AND ANTI- PD1 BLOCKADE IN RARE TUMORS-
INTERVENTIONAL
Phase:
Phase 2
Criteria/Contacts:
Link
Approval Dates:
11/2015 to 11/2023
Location:
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER-
HOUSTON, TX
Type:
ARTEMIS TRIAL-
INTERVENTIONAL
Phase:
Criteria/Contacts:
Link
Approval Dates:
1/2016-12/2022
Location:
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER-
HOUSTON, TX
Type:
TARGETED THERAPY
Phase:
Phase 2 - no longer recruiting
Criteria/Contacts:
Link
Link

We are aware of the challenges cancer patients endure while being enrolled in a clinical trial. We have partnered with Lazarex to provide those diagnosed with metaplastic breast cancer support with travel and lodging expenses if they are enrolled in an FDA-approved clinical trial. 

For more information email us at: admin@mpbcalliance.org.